NLRP3 activators disrupt the endocytic AP2 complex and plasma membrane signaling

This study identifies the disruption of the endocytic AP2 complex as a common upstream mechanism by which diverse NLRP3 activators impair plasma membrane signaling, thereby triggering inflammasome activation and cell death.

The Gist

The Big Picture: The Cell's "Smoke Alarm"

Imagine your body is a massive city, and your immune cells are the firefighters. Inside these firefighters, there is a very sensitive smoke alarm called NLRP3.

Usually, this alarm only goes off when there is a real fire (like a bacterial infection or a virus). When it goes off, it triggers a massive response: the cell sounds the siren (releasing inflammatory signals) and, if the fire is too big, it blows up the building to stop the fire from spreading (a process called pyroptosis, or programmed cell death).

For a long time, scientists knew that many different things could set off this alarm:

• Potassium leaks: Like a pipe bursting.
• Mitochondrial trouble: Like the power plant failing.
• Trash pile-ups: Like the recycling center getting clogged.

The big mystery was: How do all these different problems trigger the same alarm? It seemed like the cell had a million different ways to break, but they all led to the same result.

The Discovery: The "Traffic Cop" on the Cell Wall

In this study, the researchers acted like detectives. They took a snapshot of the cell's interior while it was being attacked by different "triggers" to see what was moving around.

They found something surprising. While different triggers caused different parts of the cell to scramble (like the power plant or the recycling center), one specific thing happened in every single case:

The AP2 Complex got kicked off the cell's outer wall.

The Analogy:
Think of the cell membrane (the outer wall) as a busy airport terminal.

• The AP2 Complex is the Traffic Cop standing at the gate.
• The GPCRs (receptors) are the Airline Agents who talk to the outside world (telling the cell where to go, when to eat, or when to move).
• Clathrin is the conveyor belt that brings luggage inside.

Normally, the Traffic Cop (AP2) directs the Airline Agents to the conveyor belt so they can go inside and do their job. This is how the cell "listens" to the outside world.

What the paper found:
When the NLRP3 alarm is triggered, the Traffic Cop (AP2) is suddenly fired and dragged away from the gate.

• The Airline Agents (receptors) are left standing there, unable to get on the conveyor belt.
• The cell becomes deaf and blind to the outside world. It can't hear instructions to move or stop.
• The cell enters a "Frozen State."

The researchers concluded that the immune system doesn't just react to "damage"; it reacts to silence. If the cell can't talk to the outside world anymore (because the Traffic Cop is gone), the immune system assumes something is terribly wrong and blows the siren.

The "Accidental" Discovery: Dynasore

The researchers were testing a drug called Dynasore. They thought it was just a tool to stop the conveyor belt (endocytosis).

• The Twist: They found that Dynasore didn't just stop the belt; it fired the Traffic Cop (AP2) and set off the NLRP3 alarm, even without causing a potassium leak.
• The Villain: They discovered Dynasore was accidentally sticking to a protein called NME1/2.
  • The Metaphor: NME1/2 is like the fuel pump for the conveyor belt. Dynasore jammed the fuel pump. Without fuel, the Traffic Cop couldn't stay at the gate, so he fell off.
  • This proved that jamming the "fuel pump" is enough to trigger the alarm, regardless of whether the cell is actually dying yet.

Why Does This Matter?

This changes how we understand inflammation.

1. It's a "Check Engine" Light: The NLRP3 alarm isn't just a "Fire!" signal. It's a "Check Engine" light. It says, "Hey, the cell has lost its ability to communicate with the outside world. Something is fundamentally broken."
2. The "Frozen" State: When the alarm goes off, the cell stops moving and stops listening. This explains why, during severe inflammation, immune cells stop migrating to fight the infection properly—they are stuck in a frozen, panicked state.
3. New Treatments: If we can stop the "firing" of the Traffic Cop (AP2), or fix the "fuel pump" (NME), we might be able to stop dangerous inflammation (like in Alzheimer's, diabetes, or autoimmune diseases) without killing the cell.

Summary in One Sentence

The study reveals that diverse triggers for inflammation all share one common effect: they kick the cell's "traffic cop" off the wall, silencing the cell's ability to talk to the outside world, which forces the immune system to sound the alarm and trigger a defensive explosion.

Technical Summary

1. Problem Statement

The NLRP3 inflammasome is a critical innate immune sensor activated by a diverse array of structurally and mechanistically unrelated triggers (e.g., ATP, crystals, ionophores, bacterial toxins). While several downstream danger signals are known (such as $K^+$ efflux, mitochondrial ROS, and lysosomal rupture), the upstream common mechanism that unifies these disparate stimuli remains unclear. It is hypothesized that NLRP3 acts as a sensor for general organelle dysfunction, but the specific, shared molecular event preceding inflammasome assembly has not been identified. Furthermore, the relationship between endocytic disruption and NLRP3 activation requires further elucidation, particularly regarding whether endocytosis inhibition itself triggers activation or if a specific signaling node is the true target.

2. Methodology

The authors employed a multi-omics and systems biology approach to trace spatiotemporal protein movements and signaling changes:

• Dynamic Organellar Mapping (Spatial Proteomics):
  • Used immortalized bone marrow-derived macrophages (iBMDMs) deficient in ASC or Caspase-1 to prevent pyroptosis execution. This allowed the observation of upstream events without the confounding factor of cell death-induced organelle collapse.
  • Cells were primed with LPS and stimulated with various NLRP3 agonists (Nigericin, R837/Imiquimod, Dynasore, Dyngo-4a, Monensin, $K^+$-free buffer).
  • Organelles were separated via differential ultracentrifugation into five fractions.
  • SILAC (Stable Isotope Labeling by Amino acids in Cell culture) combined with Mass Spectrometry (MS) was used to quantify protein redistribution across fractions, generating "dynamic organellar maps."
• Chemoproteomics:
  • Synthesized biotinylated Dynasore and biotinylated Dyngo-4a as affinity probes.
  • Performed streptavidin pull-downs from LPS-primed macrophages followed by MS to identify direct molecular targets of Dynasore.
  • Used AlphaFold3 to predict the binding mode of Dynasore to identified targets.
• Functional Assays:
  • Genetic Perturbation: siRNA knockdown of AP2 subunits and NME proteins; overexpression of mitochondrial-targeted NME1 and phospho-mutants of NME2.
  • GPCR Signaling: Measured $\beta_2$-adrenergic receptor ($\beta_2$-AR) internalization via fluorescence microscopy and Diffusion-Enhanced Resonance Energy Transfer (DERET).
  • Arrestin Recruitment: Bioluminescence Resonance Energy Transfer (BRET) assays to assess $\beta$-arrestin recruitment to GPCRs.
  • cAMP Production: FRET-based biosensors in HEK293 cells to measure cAMP dynamics.
  • Chemotaxis: 3D collagen gel migration assays for dendritic cells (DCs) to assess directed migration.
• Phosphoproteomics: Global analysis of phosphorylation changes in NLRP3-deficient cells to identify signaling pathway alterations.

3. Key Contributions

• Identification of a Unifying Upstream Event: The study reveals that disruption of the endocytic Adaptor Protein 2 (AP2) complex is the only consistent spatial perturbation shared across all tested NLRP3 agonists, regardless of whether they are $K^+$-efflux dependent or independent.
• Discovery of Dynasore as a Novel NLRP3 Activator: The authors identified Dynasore (a known dynamin inhibitor) as a potent, $K^+$-efflux-independent NLRP3 activator. Crucially, they distinguished it from its derivative Dyngo-4a, which inhibits endocytosis but does not activate NLRP3.
• Elucidation of Dynasore's Off-Target Mechanism: Through chemoproteomics, the study identified Nucleoside Diphosphate Kinases 1 and 2 (NME1/2) as the direct molecular targets of Dynasore responsible for NLRP3 activation, rather than its canonical inhibition of dynamin.
• Linking Plasma Membrane Signaling Failure to Inflammation: The paper establishes a conceptual paradigm where NLRP3 activation is a consequence of the cell's inability to process extracellular cues due to the displacement of the AP2 complex from the plasma membrane.

4. Key Results

A. AP2 Complex Disruption is Universal

• Dynamic organellar maps showed that while mitochondrial and trans-Golgi network (TGN) perturbations were stimulus-specific, AP2 complex subunits (AP2$\alpha$, AP2$\beta$, AP2$\mu$, AP2$\sigma$) were uniformly displaced from the plasma membrane and endosomes upon activation by Nigericin, R837, and Dynasore.
• Controls like Monensin (which disrupts pH and organelles broadly) or $K^+$-free buffer (which triggers NLRP3 via osmotic stress) confirmed that AP2 displacement is specific to NLRP3 activation and not a general consequence of organelle stress.

B. Dynasore Activates NLRP3 via NME1/2

• Dynasore vs. Dyngo-4a: Both compounds inhibit endocytosis, but only Dynasore triggers IL-1$\beta$ release and pyroptosis.
• Mechanism: Dynasore does not activate NLRP3 via $K^+$ efflux (excess extracellular $K^+$ did not block activation).
• Target Identification: Biotin-Dynasore pull-downs identified NME1 and NME2 as top interactors. AlphaFold3 predicted Dynasore binding to the NME1 kinase pocket.
• Functional Validation:
  • Knockdown of AP2 subunits or NME1/2 reduced NLRP3 activation.
  • Sequestering NME1 to the mitochondria (away from the plasma membrane) reduced IL-1$\beta$ release.
  • Phospho-mimetic and phospho-dead mutants of NME2 (H118) significantly altered NLRP3 activation, suggesting histidine phosphorylation is critical.
• Conclusion: Dynasore activates NLRP3 by binding NME1/2, which leads to the displacement of the AP2 complex, independent of dynamin inhibition.

C. Impairment of GPCR Signaling and Chemotaxis

• Internalization Block: NLRP3 agonists (Dynasore, R837, Dyngo-4a) prevented the internalization of the $\beta_2$-adrenergic receptor ($\beta_2$-AR) and CCR7.
• Signaling Shutdown: Despite preserved $\beta$-arrestin recruitment, the downstream signaling was blunted.
  • cAMP production in response to norepinephrine was severely attenuated.
  • Dynamic Mass Redistribution (DMR) assays showed impaired Gi-protein signaling.
• Phosphoproteomics: NLRP3 activation led to a global dephosphorylation of proteins involved in cell surface signaling, endocytosis, and chemotaxis (including GPCRs, Rabs, and GEFs like Dock2).
• Physiological Consequence: In dendritic cells, NLRP3 agonists significantly reduced the velocity and directionality of chemotaxis toward CCL19. This effect was upstream of pyroptosis (blocked by MCC-950).

5. Significance

• New Paradigm for NLRP3 Activation: The study shifts the understanding of NLRP3 from a sensor of random organelle damage to a surveillance checkpoint for plasma membrane signaling integrity. The cell interprets the failure of essential endocytic machinery (specifically the AP2 complex) as a "danger signal."
• Unified Mechanism: It provides a common molecular explanation for how diverse triggers (ionophores, crystals, small molecules) converge: they all disrupt the AP2 complex, likely via NME1/2 modulation or similar pathways, leading to a "frozen" state of cellular signaling.
• Therapeutic Implications: The identification of NME1/2 as upstream regulators and Dynasore's specific off-target effects offers new targets for modulating inflammasome-driven diseases (e.g., CAPS, Alzheimer's, atherosclerosis). It also highlights the risk of off-target effects in drugs targeting endocytosis.
• Physiological Insight: The findings suggest that NLRP3 activation may be a mechanism to halt cellular motility and communication (chemotaxis, GPCR signaling) in response to severe environmental stress, effectively "freezing" the cell before executing pyroptosis.

In summary, this paper defines the AP2 complex disruption as the central node linking diverse NLRP3 agonists to inflammasome activation, mediated by the interaction of small molecules (like Dynasore) with NME1/2, resulting in a collapse of plasma membrane signaling and chemotactic ability.